Health
Newly identified biomarker could predict response to immune checkpoint inhibitors – News-Medical.net
A team of Roswell Park Comprehensive Cancer Center researchers has identified a new biomarker that could predict response to immune checkpoint inhibitors (ICI)…
A team of Roswell Park Comprehensive Cancer Center researchers has identified a new biomarker that could predict response to immune checkpoint inhibitors (ICI) shortly after patients with non-small cell lung cancer (NSCLC) initiate therapy. This discovery, published today in the journal Nature Communications, is not only an important step forward in lung cancer treatment, but also has implications for other malignancies, according to lead author Fumito Ito, MD, PhD, FACS.
“Although ICIs revolutionized…
-
Noosa News17 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News19 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
Noosa News15 hours agoFranz Ferdinand: Australian Tour 2025
-
General16 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win